OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Officer exercised or converted 4,179 CRL derivative securities | OQRO

Home
Insider trades
Charles River Laboratories
Officer exercised or converted 4,179 CRL derivative securities

Insider trades

Insider trade

Officer exercised or converted 4,179 CRL derivative securities

Traded Aug 6, 2026 · Filed Aug 10, 2026

CRLCharles River LaboratoriesCRL

4,179
Shares · @ $179.66

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Aug 6, 2026
Reporting period: Not applicable
Filed with the SEC: Aug 10, 2026

OfficerOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001100682-26-000122

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Aug 10, 2026, 8:35 PM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Issuer CIK

1100682

Ticker

CRL

Reporting person

Victoria L Creamer

Relationship

Officer

Officer title

EVP & Chief People Officer

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Aug 6, 2026

Transaction code

Shares / units

4,179

Price per share

$179.66

Acquired / disposed

Acquired (A)

Shares owned after

34,230

Ownership form

Direct

Amendment

Around the same time

6w ago

21KShares · @ $194.12

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

6w ago

12KShares · @ $208.44

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Director sold ~$10.1M of Charles River Laboratories

Scheduled in advance6w ago